XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Cash flows used in operating activities:        
Net loss $ (9,860) $ (7,691) $ (30,199) $ (26,985)
Adjustments to reconcile net loss to net cash used in operating activities:        
Stock-based compensation     4,640 5,258
Operating lease right-of-use asset     711 1,024
Depreciation     234 173
Amortization of premium (Accretion of discount) on marketable debt securities     (331) 1,029
Changes in operating assets and liabilities:        
Prepaid expenses and other current assets     (1,919) (433)
Other assets     (2,297) 131
Accounts payable     918 (498)
Accrued expenses     68 (135)
Operating lease liabilities     (682) (995)
Net cash used in operating activities     (28,857) (21,431)
Cash flows from investing activities:        
Purchase of marketable debt securities     (12,186) (14,428)
Proceeds from maturity and redemption of marketable debt securities     50,820 47,837
Purchase of property and equipment     (45) (114)
Net cash provided by investing activities     38,589 33,295
Cash flows from financing activities:        
Repurchase of shares in connection with settlement of RSUs     (91) (90)
Net cash used in financing activities     (91) (90)
Net increase (decrease) in cash and cash equivalents and restricted cash     9,641 11,774
Cash and cash equivalents and restricted cash - beginning of year     24,872 36,469
Cash and cash equivalents and restricted cash - end of period 34,513 48,243 34,513 48,243
Reconciliation of cash and cash equivalents and restricted cash to the condensed consolidated balance sheets:        
Cash and cash equivalents 33,768 47,498 33,768 47,498
Restricted cash, non-current 745 745 745 745
Cash and cash equivalents and restricted cash $ 34,513 $ 48,243 $ 34,513 $ 48,243